As the NBA free agency kicks off, the Philadelphia 76ers find themselves in a tricky spot with guard Quentin Grimes. With a crowded backcourt featuring Tyrese Maxey, De'Anthony Melton, and rookie Jared McCain, matching a potential 4-year, $14.1 million offer sheet for Grimes could be financial poison. This analysis breaks down why a rival team (hello, Houston) could exploit Philly's roster crunch with a shrewd 'poison pill' contract structure – complete with player options and tax implications. We'll examine the cap mechanics, Grimes' fit in competing systems, and how Daryl Morey's old team might return the favor for his China controversy fallout.